Anixa Biosciences, Inc.
At Close: 4:00 PM
ANIX Stock Price Graph
ANIX Stock Price Today
Anixa Biosciences, Inc. (ANIX) stock rallied over 7.74% intraday to trade at $3.34 a share on NASDAQ. The stock opened with a gain of 0.65% at $3.12 and touched an intraday high of $3.27, rising 7.74% against the last close of $3.10. The Anixa Biosciences, Inc. in stock market went to a low of $3.04 during the session.
ANIX Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ANIX Stock Price History Chart
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Frequently Asked Questions
What is the current Anixa Biosciences, Inc. (ANIX) stock price?
Anixa Biosciences, Inc. (NASDAQ: ANIX) stock price is $3.34 in the last trading session. During the trading session, ANIX stock reached the peak price of $3.27 while $3.04 was the lowest point it dropped to. The percentage change in ANIX stock occurred in the recent session was 7.74% while the dollar amount for the price change in ANIX stock was $0.24.
ANIX's industry and sector of operation?
The NASDAQ listed ANIX is part of Biotechnology industry that operates in the broader Healthcare sector. Anixa Biosciences, Inc. , a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
Who are the executives of ANIX?
Dr. Amit Kumar Ph.D.
Chairman & Chief Executive Officer
Mr. Michael J. Catelani CPA, MBA
Pres, Chief Operating Officer, Chief Financial Officer & Corporation Sec.
Dr. Pamela D. Garzone Ph.D.
Chief Devel. Officer
Mr. Michael J. Catelani CPA, MBA
Pres, COO, CFO & Corp. Sec.
How ANIX did perform over past 52-week?
ANIX's closing price is 0.44% higher than its 52-week low of $2.84 where as its distance from 52-week high of $6.45 is -0.38%.
How many employees does ANIX have?
Number of ANIX employees currently stands at 5.00. ANIX operates from 3150 Almaden Expressway, San Jose, CA 95118, US.
Link for ANIX official website?
Official Website of ANIX is: https://www.anixa.com
How do I contact ANIX?
How many shares of ANIX are traded daily?
ANIX stock volume for the day was 44943.00 shares. The average number of ANIX shares traded daily for last 3 months was 46.7 Thousands.
What is the market cap of ANIX currently?
The market value of ANIX currently stands at $103.77 Million with its latest stock price at $3.34 and 30.91 Million of its shares outstanding.